Skip to main content
Log in

Epidermolysis Bullosa Pruriginosa: A Systematic Review Exploring Genotype–Phenotype Correlation

  • Systematic Review
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Introduction

Epidermolysis bullosa pruriginosa (EBP) is a clinical variant of dystrophic epidermolysis bullosa (DEB), characterized by intense pruritus and hypertrophic, lichenified, prurigo-like papules, plaques, and nodules secondary to scratching. These clinical findings have been attributed to various mutations in the COL7A1 gene. Previous reports have yielded inconsistent findings regarding a possible genotype–phenotype relationship in EBP.

Objective

Our aim was to conduct a systematic review aimed at assessing the genotype–phenotype correlation in EBP.

Methods

A systematic review was conducted using PubMed, Medline, EMBASE, and Cochrane databases for all reports of mutation-verified EBP, published from 1946 to September 2014. Statistical comparison of clinical findings between mutation types was performed using logistic regression analysis.

Results

The review included a total of 28 articles with 74 individuals, which consisted of level 4 non-controlled case series (grade C) and level 5 case reports (grade D). Previous reported mutation types included glycine substitution (GS, 52.7 %), in-frame skipping (IFS, 33.8 %), non-glycine substitution (NGS, 8.1 %), and premature termination codon (PTC, 5.4 %). The most common clinical findings were extremities involvement, linear configuration, and nail dystrophy. In comparison with GS mutation carriers, IFS carriers had a higher likelihood of (1) being male (OR 2.99; p = 0.043; 95 % CI 1.27–11.4) and (2) presenting with blisters (OR 4.10; p = 0.013; 95 % CI 1.34–12.5).

Conclusions

To our knowledge, this study is the first systematic review examining the relationship between mutation type and clinical presentation in EBP. The findings in this review (1) identify common clinical characteristics of EBP that may help in the assessment of patients with possible EBP; and (2) indicate that certain mutation carriers may have a higher likelihood of exhibiting particular phenotypes. In the case of potential diagnostic challenge, assessment for presence of common clinical findings as well as molecular testing may facilitate correct identification and prognostication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Fine JD, Eady RA, Bauer EA, Bauer JW, Buckner-Tuderman L, Heagerty A, et al. The classification of inherited epidermolysis bullosa (EB): report of the third international consensus meeting on diagnosis and classification of EB. J Am Acad Dermatol. 2008;58(6):931–50.

    Article  PubMed  Google Scholar 

  2. Tey HL, Lee AD, Almaani N, McGrath JA, Mills KC, Yosipovitch G. Epidermolysis bullosa pruriginosa masquerading as psychogenic pruritus. Arch Dermatol. 2011;147(8):956–60.

    Article  CAS  PubMed  Google Scholar 

  3. McGrath JA, Schofield OM, Eady RA. Epidermolysis bullosa pruriginosa: dystrophic epidermolysis bullosa with distinctive clinicopathological features. Br J Dermatol. 1994;130(5):617–25.

    Article  CAS  PubMed  Google Scholar 

  4. Banky JP, Sheridan AT, Storer EL, Marshman G. Successful treatment of epidermolysis bullosa pruriginosa with topical tacrolimus. Arch Dermatol. 2004;140(7):794–6.

    Article  PubMed  Google Scholar 

  5. Schumann H, Has C, Kolhase J, Bruckner-Tuderman L. Dystrophic epidermolysis bullosa pruriginosa is not associated with frequent FLG gene mutations. Br J Dermatol. 2008;159(2):464–9.

    Article  CAS  PubMed  Google Scholar 

  6. Broekaert SM, Knauss-Scherwitz E, Biedermann T, et al. Epidermolysis bullosa pruriginosa due to a glycine substitution mutation in the COL7A1-gene. Acta Derm Venereol. 2006;86(6):556–7.

    Article  PubMed  Google Scholar 

  7. Jones RR. Epidermolysis bullosa. Report of a family and discussion of the dominant dystrophic types. Clin Exp Dermatol. 1979;4(3):303–8.

    Article  CAS  PubMed  Google Scholar 

  8. Dang N, Klingberg S, Marr P, Murrell DF. Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants. J Dermatol Sci. 2007;46(3):168–78.

    Article  Google Scholar 

  9. Lee JY, Pulkkinen L, Liu HS, Chen YF, Uitto J. A glycine-to-arginine substitution inthe triple-helical domain of type VII collagen in a family with dominant dystrophic epidermolysis bullosa pruriginosa. J Invest Dermatol. 1997;108(6):947–9.

    Article  CAS  PubMed  Google Scholar 

  10. Mellerio JE, Ashton GH, Mohammedi R, Lyon CC, Kirby B, Harman KE, et al. Allelic heterogeneity of dominant and recessive COL7A1 mutations underlying epidermolysis bullosa pruriginosa. J Invest Dermatol. 1999;112(6):984–7.

    Article  CAS  PubMed  Google Scholar 

  11. Whittock NV, Ashton GH, Mohammedi R, Mellerio JE, Matthew CG, Abbs SJ, et al. Comparative mutation detection screening of the type VII collagen gene (COL7A1) using the protein truncation test, fluorescent chemical cleavage of mismatch, and conformation sensitive gel electrophoresis. J Invest Dermatol. 1999;113(4):673–86.

    Article  CAS  PubMed  Google Scholar 

  12. Murata T, Masunaga T, Shimizu H, Takizawa Y, Ishiko A, Hatta N, et al. Glycine substitution mutations by different amino acids in the same codon of COL7A1 lead to heterogeneous clinical phenotypes of dominant dystrophic epidermolysis bullosa. Arch Dermatol Res. 2000;292(10):477–81.

    Article  CAS  PubMed  Google Scholar 

  13. Jiang W, Bu D, Yang Y, Zhu X. A novel splice site mutation in collagen type VII gene in a Chinese family with dominant dystrophic epidermolysis bullosa pruriginosa. Acta Derm Venereol. 2002;82(3):187–91.

    Article  CAS  PubMed  Google Scholar 

  14. Nakamura H, Sawamura D, Goto M, Sato-Matsumura KC, LaDuca J, Lee JY, et al. The G2028R glycine substitution mutation in COL7A1 leads to marked inter-familiar clinical heterogeneity in dominant dystrophic epidermolysis bullosa. J Dermatol Sci. 2004;34(3):195–200.

    Article  CAS  PubMed  Google Scholar 

  15. Chuang GS, Martinez-Mir A, Yu HS, Sung FY, Chuang RY, Cserhalmi-Friedman PB, et al. A novel missense mutation in the COL7A1 gene underlies epidermolysis bullosa pruriginosa. Clin Exp Dermatol. 2004;29(3):304–7.

    Article  CAS  PubMed  Google Scholar 

  16. Drera B, Castiglia D, Zoppi N, Gardella R, Tadini G, Floriddia G, et al. Dystrophic epidermolysis bullosa pruriginosa in Italy: clinical and molecular characterization. Clin Genet. 2006;70(4):339–47.

    Article  CAS  PubMed  Google Scholar 

  17. Ee HL, Liu L, Goh CL, McGrath JA. Clinical and molecular dilemmas in the diagnosis of familial epidermolysis bullosa pruriginosa. J Am Acad Dermatol. 2007; 56(5 suppl):S77–S81.

  18. Almaani N, Liu L, Harrison N, Tanaka A, Lai-Cheong J, Mellerio JE, et al. New glycine substitution mutations in type VII collagen underlying epidermolysis bullosa pruriginosa but the phenotype is not explained by a common polymorphism in the matrix metalloproteinase–1 gene promoter. Acta Derm Venereol. 2009;89(1):6–11.

    Article  CAS  PubMed  Google Scholar 

  19. Oxford Centre for Evidence-based Medicine—levels of evidence. University of Oxford, Medical Sciences Division. March 2009. http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/. Accessed 03 Dec 2014.

  20. De Irala J, Navajas RF, del Castillo AS. Abnormally wide confidence intervals in logistic regression: interpretation of statistical program results. Pan Am J Public Health. 1997;1(3):230–4.

    Article  Google Scholar 

  21. Armstrong RA. When to use the Bonferroni correction. Ophthalmic Physiol Opt. 2014;34:502–8.

    Article  PubMed  Google Scholar 

  22. Nagy N, Tanaka A, Techanukul T, McGrath JA. Common IL-31 gene haplotype associated with non-atopic eczema is not implicated in epidermolysis bullosa pruriginosa. Acta Derm Venereol. 2010;90(6):631–2.

    Article  PubMed  Google Scholar 

  23. Mangold AR, Cole CM, DiCaudo DJ, Pittelkow MR, Sekulic A. Treatment of epidermolysis bullosa pruriginosa using systemic and topical agents. J Am Acad Dermatol. 2014;70(6):e136–7.

    Article  PubMed  Google Scholar 

  24. Vivehanantha S, Carr RA, McGrath JA, Taibiee SM, Madhogaria S, Ilchyshyn A. Epidermolysis bullosa pruriginosa: a case with prominent histopathologic inflammation. JAMA Dermatol. 2013;149(6):727–31.

    Article  PubMed  Google Scholar 

  25. Tang MM, Leong KF, Cristina H, Bruckner-Tuderman L. Dystrophic epidermolysis bullosa pruriginosa: the first report of a family in Malaysia. Med J Malaysia. 2013;68(1):81–5.

    PubMed  Google Scholar 

  26. Fortuna G, Di Lorenzo M, Cepeda-Valdes R, Garcia-Garcia C, Salas-Alanis JC. The largest family of the Americas with dominant dystrophic epidermolysis bullosa pruriginosa: a 18-year longitudinal genotype-phenotype study. J Dermatol Sci. 2013;71(3):217–21.

    Article  PubMed  Google Scholar 

  27. Yang CS, Lu Y, Farhi A, Nelson-Williams C, Kashgarian M, Glusac EJ, et al. An incompletely penetrant novel mutation in COL7A1 causes epidermolysis bullosa pruriginosa and dominant dystrophic epidermolysis bullosa phenotypes in an extended kindred. Pediatr Dermatol. 2012;29(6):725–31.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Yajima M, Nakano H, Sawamura D, Miyachi Y, Kabashima K. Case of dominant dystrophic epidermolysis bullosa pruriginosa with a c.7868G>A (G2623D) mutation in type VII collagen. J Dermatol. 2012;39(12):1087–8.

    Article  PubMed  Google Scholar 

  29. Jiang W, Sun TT, Lei PC, Zhu XJ. Genotype-phenotype correlation in Chinese patients with dystrophic epidermolysis bullosa pruriginosa. Acta Derm Venereol. 2012;92(1):50–3.

    Article  CAS  PubMed  Google Scholar 

  30. Brick K, Hand JL, Frankel AS, Siegel DH, Thomas KB, El-Azhary R, et al. Epidermolysis bullosa pruriginosa: further clarification of the phenotype. Pediatr Dermatol. 2012;29(6):732–7.

    Article  PubMed  Google Scholar 

  31. Pruneddu S, Castiglia D, Floriddia G, Cottoni F, Zambruno G. COL7A1 recessive mutations in two siblings with distinct subtypes of dystrophic epidermolysis bullosa: pruriginosa versus nails only. Dermatology. 2011;222(1):10–4.

    Article  PubMed  Google Scholar 

  32. Murase K, Kanoh H, Ishii N, Hashimoto T, Nakano H, Sawamura D, et al. Bullous dermolysis of the newborn and dystrophic epidermolysis bullosa pruriginosa within the same family: two phenotypes associated with a COL7A1 mutation. Acta Derm Venereol. 2011;91(6):730–1.

    CAS  PubMed  Google Scholar 

  33. Hayashi M, Kawaguchi M, Hozumi Y, Nakano H, Sawamura D, Suzuki T. Dystrophic epidermolysis bullosa pruriginosa of elderly onset. J Dermatol. 2011;38(2):173–8.

    Article  CAS  PubMed  Google Scholar 

  34. Covaciu C, Grosso F, Pisaneschi E, Zambruno G, Gregersen PA, Sommerlund M, et al. A founder synonymous COL7A1 mutation in three Danish families with dominant dystrophic epidermolysis bullosa pruriginosa identifies exonic regulatory sequences required for exon 87 splicing. Br J Dermatol. 2011;165(3):678–82.

    Article  CAS  PubMed  Google Scholar 

  35. Cole C, Sekulic A, DiCaudo D. Epidermolysis bullosa pruriginosa: novel compound heterozygote splice site mutations. J AM Acad Dermatol. 2011;64(2 Suppl):AB94.

  36. Shi BJ, Feng J. A novel missense mutation in the COL7A1 gene causes epidermolysis bullosa pruriginosa. Clin Exp Dermatol. 2009;34(8):e975–8.

    Article  PubMed  Google Scholar 

  37. Ren X, Liu JY, Zhai LY, Yao Q, Dai X, Cai Z. A splicing mutation in the COL7A1 gene causes autosomal dominant dystrophic epidermolysis bullosa pruriginosa. Br J Dermatol. 2008;158(3):618–20.

    Article  CAS  PubMed  Google Scholar 

  38. Wang Y, Zhao J, Tu P, Jiang W, Zhu X. A novel missense mutation in COL7A1 in a Chinese pedigree with epidermolysis bullosa pruriginosa. J Dermatol Sci. 2007;46(3):211–3.

    Article  CAS  PubMed  Google Scholar 

  39. Saito M, Masunaga T, Ishiko A. A novel de novo splice-site mutation in the COL7A1 gene in dominant dystrophic epidermolysis bullosa (DDEB): specific exon skipping could be a prognostic factor for DDEB pruriginosa. Clin Exp Dermatol. 2009;34(8):e934–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosures

Funding:

No funding was received.

Conflicts of interest

W. Kim, A. Alavi, S. Walsh, S. Kim, and E. Pope declare that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Whan B. Kim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, W.B., Alavi, A., Walsh, S. et al. Epidermolysis Bullosa Pruriginosa: A Systematic Review Exploring Genotype–Phenotype Correlation. Am J Clin Dermatol 16, 81–87 (2015). https://doi.org/10.1007/s40257-015-0119-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-015-0119-7

Keywords

Navigation